Drug Channels

MARCH 10, 2023

Stacey discusses digital hubs and the affordability advantages they offer both patients on specialty therapies and their health care providers. To learn more, click here to schedule a meeting with AssistRx at Asembia’s Specialty Pharmacy Summit on April 30 to May 4, 2023. Read more » Copyright © 2006-2023 Pembroke Consulting, Inc.

Specialty Pharmacies 80

Specialty Pharmacies Pharmacy Therapies Marketing 80

Drug Channels

JANUARY 27, 2023

Saket discusses market access and contracting strategies for medical benefit products when pharmacy benefit biosimilar therapies launch. Read more » Copyright © 2006-2023 Pembroke Consulting, Inc. He then describes how to automate formulary and medical policies to protect manufacturers from overpayment.

Biosimilars 77

Biosimilars Pharmacy Therapies Production 77

Drug Channels

APRIL 8, 2022

He goes on to describe four new categories of patient solutions and pharmacy models specific to this growing market segment. To learn more about CoAssist and AssistRx specialty therapy initiation and patient support services, click here to schedule a meeting with AssistRx at the Asembia Specialty Pharmacy Summit on May 2-5, 2022.

Specialty Pharmacies 72

Specialty Pharmacies Production Pharmacy Therapies 72

Drug Channels

MARCH 11, 2022

Learn more about AssistRx’s specialty therapy initiation and patient support services at Asembia's Specialty Pharmacy Summit on May 2-5, 2022. Read more » Copyright © 2006-2022 Pembroke Consulting, Inc. Stacey analyzes trends in patient support services and reimbursement hubs. Click here to schedule your meeting.

Specialty Pharmacies 74

Specialty Pharmacies Pharmacy Therapies Marketing 74

Drug Channels

NOVEMBER 17, 2023

Maria discusses the challenges patients and healthcare providers face accessing specialty therapies. She introduces us to ACTICS ® eAccess , EVERSANA’s technology platform for electronic prior authorization and benefits verification that can be used for both the pharmacy benefit and the medical benefit. Read on for Maria’s insights.

Pharmacy 74

Pharmacy Therapies Drugs 74

Drug Channels

NOVEMBER 24, 2020

In this issue: Rebate rule redux Most Favored Nation and healthcare benchmarking Amazon’s pharmacy customer opportunity Drug spending realities updated GPO consolidation Plus, I congratulate Dirk Rodgers of RxTrace on his retirement. Read more » Copyright © 2006-2020 Pembroke Consulting, Inc. to 1:15 p.m. to 1:15 p.m.

Pharmacy 52

Pharmacy Specialty Pharmacies Biosimilars Doctors 52

Drug Channels

MAY 9, 2023

Last week, Paula and I had the pleasure of attending Asembia’s 2023 Specialty Pharmacy Summit at the wonderful Wynn Las Vegas. Read more » Copyright © 2006-2023 Pembroke Consulting, Inc. As I do every year, I will violate Vegas code and tell you what happened there. Yes, that sounds about right. d/b/a Drug Channels Institute.

Specialty Pharmacies 78

Specialty Pharmacies Marketing Pharmacy Drugs 78

Drug Channels

APRIL 16, 2021

Jeff discusses aspects of our drug pricing system that lead to decreased new and refill prescription volume, higher out-of-pocket costs for patients, and therapy abandonment. Read more » Copyright © 2006-2021 Pembroke Consulting, Inc. Read on for Jeff’s insights. d/b/a Drug Channels Institute.

Production 52

Production Pharmacy Therapies Drugs 52

Drug Channels

SEPTEMBER 18, 2020

Ela discusses the important role independent specialty pharmacies play in educating payers, supporting patients, and ultimately getting potentially life-saving therapies into the hands of patients. Read more » Copyright © 2006-2020 Pembroke Consulting, Inc. Read on for Ela’s insights. d/b/a Drug Channels Institute.

Specialty Pharmacies 40

Specialty Pharmacies Pharmacy Drugs Therapies 40

Drug Channels

FEBRUARY 23, 2021

In this issue: Payers confess: Patients lose from copay accumulators Humana joins the Express Scripts GPO Hospitals vs. PBMs over specialty pharmacy white bagging Let’s all follow the Buy-and-Bill Dollar! Plus, entrepreneurial pharmacy owner Dave Marley demonstrates the power of innovation. Sometimes, the little guy wins big.

Pharmacy 52

Pharmacy Specialty Pharmacies Hospitals Independent Pharmacies 52

Drug Channels

MAY 31, 2024

Jan then highlights how the right vendor can help overcome these challenges for both pharmacy and medical benefit products. To learn more about AssistRx’s solutions for medical benefit products, read their latest case study: eMedical Benefit Verification: Improving Speed to Therapy and Patient & HCP Experiences.

Pharmacy 52

Pharmacy Science Therapies Production 52

Drug Channels

AUGUST 13, 2021

Stacey discusses how a patient support vendor can help specialty pharmacy patients attain prior authorizations and access critical therapies. Read more » Copyright © 2006-2021 Pembroke Consulting, Inc. She offers three criteria that manufacturers can use to evaluate e-support services providers. Read on for Stacey’s insights.

Specialty Pharmacies 54

Specialty Pharmacies Pharmacy Therapies Marketing 54

Drug Channels

OCTOBER 17, 2022

Don’t miss the chance to unite with colleagues and master the complexities of pharmacy and distribution models to accelerate patient access! Copyright © 2006-2022 Pembroke Consulting, Inc. The content of Sponsored Posts does not necessarily reflect the views of Pembroke Consulting, Inc., Drug Channels, or any of its employees.

Biosimilars 58

Biosimilars Pharmacy Therapies Production 58

Drug Channels

MAY 22, 2023

WHAT YOU WILL LEARN As expensive specialty therapies come to dominate drug spending, pharmaceutical manufacturers are paying a growing share of patents’ out-of-pocket costs for these prescriptions. Pharmacies and Pharmacy Benefit Managers. Copyright © 2006-2023 Pembroke Consulting, Inc. d/b/a Drug Channels Institute.

Pharmacy 73

Pharmacy Drugs Marketing Therapies 73

Drug Channels

JANUARY 12, 2021

Once again, the three largest pharmacy benefit managers (PBMs)—Caremark (CVS Health), Express Scripts (Cigna), and OptumRx (United Health Group)—have increased the number of drugs they have excluded from their standard formularies. . I also highlight the expansion of exclusions into major specialty therapy classes.

Pharmacy 52

Pharmacy Drugs Therapies Production 52

Drug Channels

MARCH 22, 2021

Once again, the three largest pharmacy benefit managers (PBMs)—Caremark (CVS Health), Express Scripts (Cigna), and OptumRx (United Health Group)—have increased the number of drugs they have excluded from their standard formularies. . I also highlight the expansion of exclusions into major specialty therapy classes.

Pharmacy 52

Pharmacy Drugs Therapies Production 52

Drug Channels

JUNE 5, 2023

Join peers this August to discover the evolving specialty pharmacy marketplace, build multi-stakeholder partnerships, and explore frameworks to inform your 2024 distribution and patient service strategies. Copyright © 2006-2023 Pembroke Consulting, Inc. d/b/a Drug Channels Institute.

Specialty Pharmacies 55

Specialty Pharmacies Pharmacy Biosimilars Compliance 55

Drug Channels

OCTOBER 19, 2020

Channel Strategy for First Medical Product – A Look at Channel Considerations for Pharmacy vs. Medical Plus – Tailored Track Options Based on Company Size : Emerging/Small Companies – Infrastructure Set-Up, License Procurement and 3PL Contracting Mid-Large Companies – How Do I Think About My Portfolio Differently Based on Product Type?

Specialty Pharmacies 52

Specialty Pharmacies Science Pharmacy Licensing 52

Drug Channels

SEPTEMBER 21, 2020

This important event convenes key stakeholders including manufacturers, specialty pharmacies, hubs, payers, PBMs, physicians and more to explore strategies for developing and integrating hub programs and other patient-centric services to ensure product access and optimal reimbursement. Copyright © 2006-2020 Pembroke Consulting, Inc.

Specialty Pharmacies 52

Specialty Pharmacies Pharmacy Pharmaceuticals Production 52

Drug Channels

NOVEMBER 8, 2020

Copyright © 2006-2020 Pembroke Consulting, Inc. Stuart Parker, Senior Director, Trade Relations, Mayne Pharma And more! Other restrictions may apply. The content of Sponsored Posts does not necessarily reflect the views of Pembroke Consulting, Inc., Drug Channels, or any of its employees. d/b/a Drug Channels Institute.

Specialty Pharmacies 52

Specialty Pharmacies Science Pharmacy Pharmaceuticals 52

Drug Channels

JUNE 26, 2023

Copyright © 2006-2023 Pembroke Consulting, Inc. View the agenda for Health Systems & Pharma Partnering 2023 to see the complete picture – the program, speakers, and more, and visit www.informaconnect.com/health-systems-partnering for further details and to register. Drug Channels, or any of its employees. d/b/a Drug Channels Institute.

Biosimilars 63

Biosimilars Pharmacy Science Therapies 63

Drug Channels

AUGUST 7, 2020

Today’s guest post comes from Rob Brown, VP/GM of RxCrossroads by McKesson Program Pharmacy. Rob reviews how COVID-19 is changing patient access and adherence to specialty therapies. Read more » Copyright © 2006-2020 Pembroke Consulting, Inc. To learn more, visit www.McKesson.com/RxCrossroads. Read on for Rob’s insights.

Pharmacy 40

Pharmacy Therapies Drugs 40

Drug Channels

FEBRUARY 6, 2024

Access USA will unite PAP – Patient Assistance & Access Programs, Hub and Specialty Pharmacy Models East and the Rare Disease Summit three influential access conferences under one roof for one week of collaborative discussions and opportunities to expand your network and establish powerful partnerships. What is Access USA?

Specialty Pharmacies 40

Specialty Pharmacies Pharmacy Pharma Companies Disease 40

Drug Channels

DECEMBER 1, 2020

Pharmacy and healthcare provider markets experienced unprecedented volatility. Read more » Copyright © 2006-2020 Pembroke Consulting, Inc. During 2020, the COVID-19 pandemic disrupted every aspect of the pharmaceutical channel—and our lives. This year has demonstrated the underlying resilience of U.S. to 1:15 p.m.

Pharmacy 40

Pharmacy Vaccine Drugs Pharmaceuticals 40

Drug Channels

MAY 10, 2021

Copyright © 2006-2021 Pembroke Consulting, Inc. Choose between 3 Interactive Workshops on Day 2! Offer not valid academic/non-profit registrations. The content of Sponsored Posts does not necessarily reflect the views of Pembroke Consulting, Inc., Drug Channels, or any of its employees. d/b/a Drug Channels Institute.

Pharmacy 40

Pharmacy Marketing Therapies Drugs 40

Agency IQ

SEPTEMBER 15, 2023

In 2006, the FDA amended its final rule to add phenylephrine bitartrate (an effervescent formulation) to phenylephrine hydrochloride as GRASE over-the-counter nasal decongestant products included in that final monograph. Another meta-analysis was conducted by industry in 2007, which came to the opposite conclusion.

Science 40

Science FDA Clinical Trials Clinical Pharmacology 40